Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06296550 · ClinicalTrials.gov registry record · NA

Enhancing Digitally Delivered Diabetes Education With Real-Time CGM

A NA study of Diabetes Type 2, sponsored by Scripps Whittier Diabetes Institute.

Recruiting
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT06296550 is a NA study of Diabetes Type 2 that is actively recruiting participants, run by Scripps Whittier Diabetes Institute. The registered enrollment target is 140 participants, below the 736-participant average among 21 other Diabetes Type 2 trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06296550, a NA study of Diabetes Type 2, is actively recruiting participants, sponsored by Scripps Whittier Diabetes Institute.

RECRUITING
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.

Conditions Studied

Diabetes Type 2

Interventions

  • OTHER Dulce Digital Text Messaging Intervention
  • OTHER CGM Device

Study Locations (1)

California

  • Scripps Whittier Diabetes Institute - San Diego

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2025-04-03
Est. Completion 2027-04-30
Phase NA

Sponsor

Scripps Whittier Diabetes Institute

17 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06296550

The ClinicalTrials.gov registry entry for NCT06296550 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 736-participant average among 21 other Diabetes Type 2 trials with a reported enrollment target (81% lower). The listed sponsor is Scripps Whittier Diabetes Institute, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Dulce Digital Text Messaging Intervention is the first listed.

NCT06296550 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06296550 about?

NCT06296550 is a clinical study titled "Enhancing Digitally Delivered Diabetes Education With Real-Time CGM". The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.

What is the current status of trial NCT06296550?

This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2025-04-03. Estimated completion is 2027-04-30.

What conditions does trial NCT06296550 study?

This clinical trial studies the following conditions: Diabetes Type 2.

What interventions are being tested in trial NCT06296550?

The interventions under investigation include: Dulce Digital Text Messaging Intervention (OTHER), CGM Device (OTHER).

Who is sponsoring clinical trial NCT06296550?

This trial is sponsored by Scripps Whittier Diabetes Institute, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06296550 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Type 2

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.